Targeting B-cell Lymphoma with Natural Killer T-cells May Be More Effective, Cheaper, Preclinical Study Shows
News
Targeting B-cell lymphoma using genetically modified natural killer T-cells — rather than general T-cells — may be a more effective, cheaper, “off-the-shelf” immunotherapy, a preclinical study suggests. The study, “Enhanced ... Read more